vs
Privia Health Group, Inc.（PRVA）与SCANSOURCE, INC.（SCSC）财务数据对比。点击上方公司名可切换其他公司
SCANSOURCE, INC.的季度营收约是Privia Health Group, Inc.的1.3倍（$766.5M vs $603.8M），SCANSOURCE, INC.净利率更高（2.2% vs 0.6%，领先1.5%），Privia Health Group, Inc.同比增速更快（25.8% vs 2.5%），过去两年Privia Health Group, Inc.的营收复合增速更高（19.6% vs 0.9%）
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
ScanSource是全球领先的专业技术分销商，主营销售点系统、条码扫描设备、网络安全产品、云服务及通信解决方案，面向北美、拉美、欧洲的增值经销商、服务提供商及企业客户，覆盖零售、医疗、工业、公共部门等领域。
PRVA vs SCSC — 直观对比
营收规模更大
SCSC
是对方的1.3倍
$603.8M
营收增速更快
PRVA
高出23.2%
2.5%
净利率更高
SCSC
高出1.5%
0.6%
两年增速更快
PRVA
近两年复合增速
0.9%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $603.8M | $766.5M |
| 净利润 | $3.7M | $16.5M |
| 毛利率 | 20.8% | 13.4% |
| 营业利润率 | 1.2% | 2.3% |
| 净利率 | 0.6% | 2.2% |
| 营收同比 | 25.8% | 2.5% |
| 净利润同比 | -27.4% | -3.3% |
| 每股收益（稀释后） | $0.02 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRVASCSC
| Q1 26 | $603.8M | — | ||
| Q4 25 | $541.2M | $766.5M | ||
| Q3 25 | $580.4M | $739.6M | ||
| Q2 25 | $521.2M | $812.9M | ||
| Q1 25 | $480.1M | $704.8M | ||
| Q4 24 | $460.9M | $747.5M | ||
| Q3 24 | $437.9M | $775.6M | ||
| Q2 24 | $422.3M | $746.1M |
净利润PRVASCSC
| Q1 26 | $3.7M | — | ||
| Q4 25 | $9.2M | $16.5M | ||
| Q3 25 | $6.9M | $19.9M | ||
| Q2 25 | $2.7M | $20.1M | ||
| Q1 25 | $4.2M | $17.4M | ||
| Q4 24 | $4.4M | $17.1M | ||
| Q3 24 | $3.5M | $17.0M | ||
| Q2 24 | $3.5M | $16.1M |
毛利率PRVASCSC
| Q1 26 | 20.8% | — | ||
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 14.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 13.0% |
营业利润率PRVASCSC
| Q1 26 | 1.2% | — | ||
| Q4 25 | 2.1% | 2.3% | ||
| Q3 25 | 2.5% | 3.5% | ||
| Q2 25 | 0.6% | 3.3% | ||
| Q1 25 | 1.1% | 3.2% | ||
| Q4 24 | 1.1% | 2.5% | ||
| Q3 24 | 1.3% | 2.3% | ||
| Q2 24 | 1.2% | 2.9% |
净利率PRVASCSC
| Q1 26 | 0.6% | — | ||
| Q4 25 | 1.7% | 2.2% | ||
| Q3 25 | 1.2% | 2.7% | ||
| Q2 25 | 0.5% | 2.5% | ||
| Q1 25 | 0.9% | 2.5% | ||
| Q4 24 | 1.0% | 2.3% | ||
| Q3 24 | 0.8% | 2.2% | ||
| Q2 24 | 0.8% | 2.2% |
每股收益（稀释后）PRVASCSC
| Q1 26 | $0.02 | — | ||
| Q4 25 | $0.08 | $0.75 | ||
| Q3 25 | $0.05 | $0.89 | ||
| Q2 25 | $0.02 | $0.87 | ||
| Q1 25 | $0.03 | $0.74 | ||
| Q4 24 | $0.03 | $0.70 | ||
| Q3 24 | $0.03 | $0.69 | ||
| Q2 24 | $0.03 | $0.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $419.5M | $83.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $805.9M | $910.9M |
| 总资产 | $1.4B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PRVASCSC
| Q1 26 | $419.5M | — | ||
| Q4 25 | $479.7M | $83.5M | ||
| Q3 25 | $441.4M | $124.9M | ||
| Q2 25 | $390.1M | $126.2M | ||
| Q1 25 | $469.3M | $146.3M | ||
| Q4 24 | $491.1M | $110.5M | ||
| Q3 24 | $422.0M | $145.0M | ||
| Q2 24 | $387.4M | $185.5M |
股东权益PRVASCSC
| Q1 26 | $805.9M | — | ||
| Q4 25 | $737.2M | $910.9M | ||
| Q3 25 | $709.1M | $914.0M | ||
| Q2 25 | $682.9M | $906.4M | ||
| Q1 25 | $659.4M | $901.7M | ||
| Q4 24 | $635.2M | $900.7M | ||
| Q3 24 | $614.9M | $920.9M | ||
| Q2 24 | $595.4M | $924.3M |
总资产PRVASCSC
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.4B | $1.7B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.3B | $1.8B | ||
| Q1 25 | $1.2B | $1.7B | ||
| Q4 24 | $1.1B | $1.7B | ||
| Q3 24 | $1.1B | $1.8B | ||
| Q2 24 | $1.1B | $1.8B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-49.5M | $30.8M |
| 自由现金流经营现金流 - 资本支出 | — | $28.9M |
| 自由现金流率自由现金流/营收 | — | 3.8% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | -13.33× | 1.87× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PRVASCSC
| Q1 26 | $-49.5M | — | ||
| Q4 25 | $127.5M | $30.8M | ||
| Q3 25 | $52.0M | $23.2M | ||
| Q2 25 | $8.0M | — | ||
| Q1 25 | $-24.1M | $66.1M | ||
| Q4 24 | $74.8M | $-6.2M | ||
| Q3 24 | $33.2M | $44.8M | ||
| Q2 24 | $34.5M | — |
自由现金流PRVASCSC
| Q1 26 | — | — | ||
| Q4 25 | — | $28.9M | ||
| Q3 25 | — | $20.8M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $64.6M | ||
| Q4 24 | — | $-8.2M | ||
| Q3 24 | — | $42.5M | ||
| Q2 24 | — | — |
自由现金流率PRVASCSC
| Q1 26 | — | — | ||
| Q4 25 | — | 3.8% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 9.2% | ||
| Q4 24 | — | -1.1% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | — |
资本支出强度PRVASCSC
| Q1 26 | — | — | ||
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.2% |
现金转化率PRVASCSC
| Q1 26 | -13.33× | — | ||
| Q4 25 | 13.93× | 1.87× | ||
| Q3 25 | 7.58× | 1.17× | ||
| Q2 25 | 2.97× | — | ||
| Q1 25 | -5.70× | 3.79× | ||
| Q4 24 | 17.00× | -0.36× | ||
| Q3 24 | 9.38× | 2.64× | ||
| Q2 24 | 9.94× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRVA
| FFS-patient care | $391.1M | 65% |
| Capitated revenue | $86.1M | 14% |
| Other | $75.0M | 12% |
| FFS-administrative services | $31.4M | 5% |
| Care management fees (PMPM) | $17.9M | 3% |
| Other revenue | $2.3M | 0% |
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
